The language-related transcription factor FOXP2 is post-translationally modified with small ubiquitin-like modifiers

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Estruch, Sara B ^a   Graham, Sarah A ^a   Deriziotis, Pelagia ^a   Fisher, Simon E ^a,b  

^a MAX PLANCK INSTITUTE FOR PSYCHOLINGUISTICS   (Netherlands)

^b RADBOUD UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; FOXP2 PROTEIN, HUMAN; LYSINE; MUTANT PROTEIN; PROTEIN BINDING; PROTEIN INHIBITOR OF ACTIVATED STAT; SUMO PROTEIN; UBIQUITIN PROTEIN LIGASE;

AMINO ACID SEQUENCE; CHEMISTRY; HEK293 CELL LINE; HUMAN; LANGUAGE; METABOLISM; PROTEIN PROCESSING; SUMOYLATION;

AMINO ACID SEQUENCE; FORKHEAD TRANSCRIPTION FACTORS; HEK293 CELLS; HUMANS; LANGUAGE; LYSINE; MUTANT PROTEINS; PROTEIN BINDING; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTEIN PROCESSING, POST-TRANSLATIONAL; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMOYLATION; UBIQUITIN-PROTEIN LIGASES;

EID: 84958576899     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep20911     Document Type: Article

References (66)

1. Lai, C. S., Fisher, S. E., Hurst, J. A., Vargha-Khadem, F. & Monaco, A. P. A forkhead-domain gene is mutated in a severe speech and language disorder. Nature 413, 519-523 (2001).
2. Nelson, C. S. et al. Microfluidic affinity and ChIP-seq analyses converge on a conserved FOXP2-binding motif in chimp and human, which enables the detection of evolutionarily novel targets. Nucleic Acids Res 41, 5991-6004 (2013).
3. Vernes, S. C. et al. Functional genetic analysis of mutations implicated in a human speech and language disorder. Hum Mol Genet 15, 3154-3167 (2006).
4. Turner, S. J. et al. Small intragenic deletion in FOXP2 associated with childhood apraxia of speech and dysarthria. Am J Med Genet A 161A, 2321-2326 (2013).
5. Adegbola, A. A. et al. Monoallelic expression of the human FOXP2 speech gene. Proc Natl Acad Sci USA 112, 6848-6854 (2015).
6. Nazaryan, L. et al. The strength of combined cytogenetic and mate-pair sequencing techniques illustrated by a germline chromothripsis rearrangement involving FOXP2. Eur J Hum Genet 22, 338-343 (2014).
7. Utine, G. E. et al. Etiological yield of SNP microarrays in idiopathic intellectual disability. Eur J Paediatr Neurol 18, 327-337 (2014).
8. Vernes, S. C. et al. Foxp2 regulates gene networks implicated in neurite outgrowth in the developing brain. PLoS Genet 7, e1002145 (2011).
9. Groszer, M. et al. Impaired synaptic plasticity and motor learning in mice with a point mutation implicated in human speech deficits. Curr Biol 18, 354-362 (2008).
10. Ferland, R. J., Cherry, T. J., Preware, P. O., Morrisey, E. E. & Walsh, C. A. Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain. J Comp Neurol 460, 266-279 (2003).
11. Lai, C. S., Gerrelli, D., Monaco, A. P., Fisher, S. E. & Copp, A. J. FOXP2 expression during brain development coincides with adult sites of pathology in a severe speech and language disorder. Brain 126, 2455-2462 (2003).
12. Fisher, S. E. & Scharff, C. FOXP2 as a molecular window into speech and language. Trends Genet 25, 166-177 (2009).
13. French, C. A. & Fisher, S. E. What can mice tell us about Foxp2 function? Curr Opin Neurobiol 28, 72-79 (2014).
14. French, C. A. et al. An aetiological Foxp2 mutation causes aberrant striatal activity and alters plasticity during skill learning. Mol Psychiatry 17, 1077-1085 (2012).
15. Garcia-Calero, E., Botella-Lopez, A., Bahamonde, O., Perez-Balaguer, A. & Martinez, S. FoxP2 protein levels regulate cell morphology changes and migration patterns in the vertebrate developing telencephalon. Brain Struct Funct doi: 10.1007/s00429-015-1079-7 (2015).
16. Tsui, D., Vessey, J. P., Tomita, H., Kaplan, D. R. & Miller, F. D. FoxP2 regulates neurogenesis during embryonic cortical development. J Neurosci 33, 244-258 (2013).
17. Haesler, S. et al. Incomplete and inaccurate vocal imitation after knockdown of FoxP2 in songbird basal ganglia nucleus Area X. PLoS Biol 5, e321 (2007).
18. Heston, J. B. & White, S. A. Behavior-linked FoxP2 regulation enables zebra finch vocal learning. J Neurosci 35, 2885-2894 (2015).
19. Haesler, S. et al. FoxP2 expression in avian vocal learners and non-learners. J Neurosci 24, 3164-3175 (2004).
20. Rochefort, C., He, X., Scotto-Lomassese, S. & Scharff, C. Recruitment of FoxP2-expressing neurons to area X varies during song development. Dev Neurobiol 67, 809-817 (2007).
21. Murugan, M., Harward, S., Scharff, C. & Mooney, R. Diminished FoxP2 levels affect dopaminergic modulation of corticostriatal signaling important to song variability. Neuron 80, 1464-1476 (2013).
22. Teramitsu, I. & White, S. A. FoxP2 regulation during undirected singing in adult songbirds. J Neurosci 26, 7390-7394 (2006).
23. Miller, J. E. et al. Birdsong decreases protein levels of FoxP2, a molecule required for human speech. J Neurophysiol 100, 2015-2025 (2008).
24. Thompson, C. K. et al. Young and intense: FoxP2 immunoreactivity in Area X varies with age, song stereotypy, and singing in male zebra finches. Front Neural Circuits 7, 24 (2013).
25. Mendoza, E. et al. Differential coexpression of FoxP1, FoxP2, and FoxP4 in the Zebra Finch (Taeniopygia guttata) song system. J Comp Neurol 523, 1318-1340 (2015).
26. Fu, L. et al. Multiple microRNAs regulate human FOXP2 gene expression by targeting sequences in its 3′ untranslated region. Mol Brain 7, 71 (2014).
27. Lozano, R., Vino, A., Lozano, C., Fisher, S. E. & Deriziotis, P. A de novo FOXP1 variant in a patient with autism, intellectual disability and severe speech and language impairment. Eur J Hum Genet 23, 1702-1707 (2015).
28. Deriziotis, P. et al. De novo TBR1 mutations in sporadic autism disrupt protein functions. Nat Commun 5, 4954 (2014).
29. Deriziotis, P., Graham, S. A., Estruch, S. B. & Fisher, S. E. Investigating protein-protein interactions in live cells using bioluminescence resonance energy transfer. J Vis Exp doi: 10.3791/51438 (2014).
30. Li, S., Weidenfeld, J. & Morrisey, E. E. Transcriptional and DNA binding activity of the Foxp1/2/4 family is modulated by heterotypic and homotypic protein interactions. Mol Cell Biol 24, 809-822 (2004).
31. Meulmeester, E. & Melchior, F. Cell biology: SUMO. Nature 452, 709-711 (2008).
32. Rytinki, M. M., Kaikkonen, S., Pehkonen, P., Jaaskelainen, T. & Palvimo, J. J. PIAS proteins: pleiotropic interactors associated with SUMO. Cell Mol Life Sci 66, 3029-3041 (2009).
33. Sakai, Y. et al. Protein interactome reveals converging molecular pathways among autism disorders. Sci Transl Med 3, 86ra49 (2011).
34. Kotaja, N., Karvonen, U., Janne, O. A. & Palvimo, J. J. PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol Cell Biol 22, 5222-5234 (2002).
35. Jakobs, A. et al. Ubc9 fusion-directed SUMOylation (UFDS): a method to analyze function of protein SUMOylation. Nat Methods 4, 245-250 (2007).
36. Kahyo, T., Nishida, T. & Yasuda, H. Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol Cell 8, 713-718 (2001).
37. Geiss-Friedlander, R. & Melchior, F. Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 8, 947-956 (2007).
38. Zhao, Q. et al. GPS-SUMO: a tool for the prediction of sumoylation sites and SUMO-interaction motifs. Nucleic Acids Res 42, W325-330 (2014).
39. Beauclair, G., Bridier-Nahmias, A., Zagury, J. F., Saib, A. & Zamborlini, A. JASSA: a comprehensive tool for prediction of SUMOylation sites and SIMs. Bioinformatics 31, 3483-3491 (2015).
40. Diella, F. et al. Understanding eukaryotic linear motifs and their role in cell signaling and regulation. Front Biosci 13, 6580-6603 (2008).
41. Diella, F. et al. KEPE-a motif frequently superimposed on sumoylation sites in metazoan chromatin proteins and transcription factors. Bioinformatics 25, 1-5 (2009).
42. Tatham, M. H., Rodriguez, M. S., Xirodimas, D. P. & Hay, R. T. Detection of protein SUMOylation in vivo. Nat Protoc 4, 1363-1371 (2009).
43. Roll, P. et al. Molecular networks implicated in speech-related disorders: FOXP2 regulates the SRPX2/uPAR complex. Hum Mol Genet 19, 4848-4860 (2010).
44. Stroud, J. C. et al. Structure of the forkhead domain of FOXP2 bound to DNA. Structure 14, 159-166 (2006).
45. Lu, M. M., Li, S., Yang, H. & Morrisey, E. E. Foxp4: a novel member of the Foxp subfamily of winged-helix genes co-expressed with Foxp1 and Foxp2 in pulmonary and gut tissues. Mech Dev 119 Suppl 1, S197-202 (2002).
46. Fontenot, J. D., Gavin, M. A. & Rudensky, A. Y. Foxp3 programs the development and function of CD4 + CD25 + regulatory T cells. Nat Immunol 4, 330-336 (2003).
47. Le Fevre, A. K. et al. FOXP1 mutations cause intellectual disability and a recognizable phenotype. Am J Med Genet A 161A, 3166-3175 (2013).
48. Horn, D. et al. Identification of FOXP1 deletions in three unrelated patients with mental retardation and significant speech and language deficits. Hum Mutat 31, E1851-1860 (2010).
49. Hamdan, F. F. et al. De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment. Am J Hum Genet 87, 671-678 (2010).
50. O'Roak, B. J. et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 43, 585-589 (2011).
51. Bacon, C. & Rappold, G. A. The distinct and overlapping phenotypic spectra of FOXP1 and FOXP2 in cognitive disorders. Hum Genet 131, 1687-1698 (2012).
52. Golebiowski, F. et al. System-wide changes to SUMO modifications in response to heat shock. Sci Signal 2, ra24 (2009).
53. Tatham, M. H., Matic, I., Mann, M. & Hay, R. T. Comparative proteomic analysis identifies a role for SUMO in protein quality control. Sci Signal 4, rs4 (2011).
54. Wen, D. et al. Important role of SUMOylation of Spliceosome factors in prostate cancer cells. J Proteome Res 13, 3571-3582 (2014).
55. Nacerddine, K. et al. The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Dev Cell 9, 769-779 (2005).
56. Loriol, C., Parisot, J., Poupon, G., Gwizdek, C. & Martin, S. Developmental regulation and spatiotemporal redistribution of the sumoylation machinery in the rat central nervous system. PLoS One 7, e33757 (2012).
57. Hasegawa, Y., Yoshida, D., Nakamura, Y. & Sakakibara, S. Spatiotemporal distribution of SUMOylation components during mouse brain development. J Comp Neurol 522, 3020-3036 (2014).
58. Gwizdek, C., Casse, F. & Martin, S. Protein sumoylation in brain development, neuronal morphology and spinogenesis. Neuromolecular Med 15, 677-691 (2013).
59. Lee, F. Y. et al. Eliminating SF-1 (NR5A1) sumoylation in vivo results in ectopic hedgehog signaling and disruption of endocrine development. Dev Cell 21, 315-327 (2011).
60. Liu, B. et al. PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity. Nat Immunol 5, 891-898 (2004).
61. Santti, H. et al. Disruption of the murine PIASx gene results in reduced testis weight. J Mol Endocrinol 34, 645-654 (2005).
62. Wong, K. A. et al. Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life. Mol Cell Biol 24, 5577-5586 (2004).
63. Marongiu, M. et al. The forkhead transcription factor Foxl2 is sumoylated in both human and mouse: sumoylation affects its stability, localization, and activity. PLoS One 5, e9477 (2010).
64. Belaguli, N. S., Zhang, M., Brunicardi, F. C. & Berger, D. H. Forkhead box protein A2 (FOXA2) protein stability and activity are regulated by sumoylation. PLoS One 7, e48019 (2012).
65. Benayoun, B. A., Caburet, S. & Veitia, R. A. Forkhead transcription factors: key players in health and disease. Trends Genet 27, 224-232 (2011).
66. Meredith, L. J. et al. The key regulator for language and speech development, FOXP2, is a novel substrate for SUMOylation. J Cell Biochem doi: 10.1002/jcb.25288 (2015).